Benitec Biopharma Inc. (BNTC:NASDAQ) rocketted at $0.79, representing a gain of 33%. On Thu, Sep 08, 2022, BNTC:NASDAQ touched a New 2-Week High of $0.79. The stock appeared on our News Catalysts scanner on Fri, Sep 02, 2022 at 08:28 AM in the 'INVESTOR UPDATE' category. From Thu, Aug 25, 2022, the stock recorded 44.44% Up Days and 10.00% Green Days
The stock spiked on Thu, Sep 08, 2022 at $1.06 with a volume of 8M+.
About Benitec Biopharma Inc. (BNTC:NASDAQ)
Benitec Biopharma Ltd is a biotechnology company which develops therapeutic technology platform that combines gene silencing and gene therapy which cures disease causing genes from single administration.
Top 10 Gainers:
- ShiftPixy, Inc. (PIXY:NASDAQ), 176.54%
- Amylyx Pharmaceuticals Inc. (AMLX:NASDAQ), 51.01%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 48.58%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 33.02%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 31.5%
- Palatin Technologies, Inc. (PTN:NYSEMKT), 26.2%
- LifeStance Health Group Inc. (LFST:NASDAQ), 25.76%
- Asana Inc. Class A (ASAN:NYSE), 24.79%
- Relay Therapeutics Inc. (RLAY:NASDAQ), 23.75%
- Revance Therapeutics, Inc. (RVNC:NASDAQ), 21.58%